Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Onechain Immunotherapeutics S.L.
Sponsor

Onechain Immunotherapeutics S.L.

Spain Carrer De Muntaner 383 3rd-2nd, 08021 Barcelona, Spain

About the sponsor

Onechain Immunotherapeutics S.L. focuses on clinical research in T-cell Acute Lymphoblastic Leukemia, with particular attention to relapsed and refractory disease and CD1a-positive patient populations.

  • Relapsed and refractory T-ALL
  • CD1a-positive leukemia
  • CAR-T cell therapy

Its research activity in this field is centered on immunotherapy for difficult-to-treat haematological malignancies.

About Specializations

Onechain Immunotherapeutics S.L. runs clinical trials in conditions such as T-cell type acute leukaemia, Precursor T-lymphoblastic lymphoma/leukaemia recurrent, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

T-cell type acute leukaemia+1

Recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
  • Sponsor:Onechain Immunotherapeutics S.L.

T-cell type acute leukaemia+1

Recruiting
InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
  • Sponsor:Onechain Immunotherapeutics S.L.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.